{"id":"W2129669150","doi":"10.1016/s1474-4422(14)70088-2","title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":false,"ca_institutions":"Paladin Labs (Canada); Arbutus Biopharma (Canada); University of Toronto","funders":"National Institute on Aging; Allos Therapeutics","keywords":"Progressive supranuclear palsy; Placebo; Double blind; Physical medicine and rehabilitation; Medicine; Physical therapy; Internal medicine; Disease; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006718783,0.0002415582,0.0006653373,0.00003924151,0.00009182058,0.00003590804,0.0004159999,0.0002423442,0.00004109437],"category_scores_gemma":[0.0001580822,0.0001290396,0.0001185295,0.00008046602,0.0002517801,0.000006161969,0.0001255993,0.0003459982,0.00001519113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003680648,"about_ca_system_score_gemma":0.00002435615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001236549,"about_ca_topic_score_gemma":0.0000458974,"domain_scores_codex":[0.9979933,0.000627883,0.0002975907,0.000473195,0.0001379254,0.0004701402],"domain_scores_gemma":[0.9990583,0.0001510054,0.0002036374,0.0004644299,0.0000524047,0.00007022541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9903787,0.0006110299,0.003110974,0.000005399095,0.00006787331,0.000004276387,0.0000165362,0.00001594491,0.003165929,0.00006884558,0.0004551605,0.002099365],"study_design_scores_gemma":[0.9751446,0.01141615,0.00243856,0.000004852953,0.00004170798,0.000004369017,0.000002640596,0.00008542444,0.00109959,0.000118589,0.00943995,0.0002035925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994046,0.00006890973,0.00005423107,0.002600645,0.0001636345,0.002359356,0.00001108517,0.00002169385,0.0006744522],"genre_scores_gemma":[0.9958843,0.00002007366,0.00004998318,0.002771946,0.0007923163,0.0003258943,0.000085034,0.00002160313,0.00004884859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01523409,"threshold_uncertainty_score":0.526208,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01814572450016573,"score_gpt":0.2714453636723508,"score_spread":0.2532996391721851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}